Since miR-29b is downregulated in CML patients, it was selected for further investigation showing that overexpression of miR-29b in the K562 CML cell line leads to a decrease of BCR::ABL1 expression. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.